FR2703251B3 - Compositions for application in human therapy, characterized by the association of a muramyl-peptide with a cytokine. - Google Patents

Compositions for application in human therapy, characterized by the association of a muramyl-peptide with a cytokine.

Info

Publication number
FR2703251B3
FR2703251B3 FR9303787A FR9303787A FR2703251B3 FR 2703251 B3 FR2703251 B3 FR 2703251B3 FR 9303787 A FR9303787 A FR 9303787A FR 9303787 A FR9303787 A FR 9303787A FR 2703251 B3 FR2703251 B3 FR 2703251B3
Authority
FR
France
Prior art keywords
muramyl
cytokine
peptide
association
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9303787A
Other languages
French (fr)
Other versions
FR2703251A1 (en
Inventor
Chedid Louis
Bahr Georges
Lefrancier Pierre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vacsyn SA
Original Assignee
Vacsyn SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9303787A priority Critical patent/FR2703251B3/en
Application filed by Vacsyn SA filed Critical Vacsyn SA
Priority to AU62856/94A priority patent/AU6285694A/en
Priority to DE69431620T priority patent/DE69431620T2/en
Priority to US08/522,342 priority patent/US5932208A/en
Priority to PCT/FR1994/000307 priority patent/WO1994021275A1/en
Priority to EP94910445A priority patent/EP0689449B1/en
Priority to JP52072694A priority patent/JP3723206B2/en
Priority to DK94910445T priority patent/DK0689449T3/en
Priority to PT94910445T priority patent/PT689449E/en
Priority to CA002157758A priority patent/CA2157758A1/en
Priority to ES94910445T priority patent/ES2187520T3/en
Priority to AT94910445T priority patent/ATE226828T1/en
Publication of FR2703251A1 publication Critical patent/FR2703251A1/en
Application granted granted Critical
Publication of FR2703251B3 publication Critical patent/FR2703251B3/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
FR9303787A 1993-03-19 1993-03-31 Compositions for application in human therapy, characterized by the association of a muramyl-peptide with a cytokine. Expired - Lifetime FR2703251B3 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
FR9303787A FR2703251B3 (en) 1993-03-31 1993-03-31 Compositions for application in human therapy, characterized by the association of a muramyl-peptide with a cytokine.
PT94910445T PT689449E (en) 1993-03-19 1994-03-21 COMPOSITIONS FOR APPLICATION IN HUMAN THERAPEUTICS CHARACTERIZED BY THE ASSOCIATION OF A MURAMILO PEPTIDE TO A CITOQUIN
US08/522,342 US5932208A (en) 1993-03-19 1994-03-21 Compositions and methods for the use of such compositions in human therapeutics, characterized by the association of a muramyl peptide with a cytokine
PCT/FR1994/000307 WO1994021275A1 (en) 1993-03-19 1994-03-21 Therapeutical compositions for use in humans, characterised by a combination of a muramyl peptide and a cytokine
EP94910445A EP0689449B1 (en) 1993-03-19 1994-03-21 Therapeutical compositions for use in humans, characterised by a combination of a muramyl peptide and a cytokine
JP52072694A JP3723206B2 (en) 1993-03-19 1994-03-21 A therapeutic composition for use in humans, characterized by combining muramyl peptide and cytokine
AU62856/94A AU6285694A (en) 1993-03-19 1994-03-21 Therapeutical compositions for use in humans, characterised by a combination of a muramyl peptide and a cytokine
DE69431620T DE69431620T2 (en) 1993-03-19 1994-03-21 COMPOSITIONS FOR USE IN HUMAN THERAPY, CHARACTERIZED BY ASSOCIATING A MURAMYL PEPTIDE WITH A CYTOKIN
CA002157758A CA2157758A1 (en) 1993-03-19 1994-03-21 Compositions for use in human therapeutics, characterised by the association of a muramyl peptide with a cytokine
ES94910445T ES2187520T3 (en) 1993-03-19 1994-03-21 COMPOSITIONS FOR APPLICATION IN HUMAN THERAPEUTICS, CHARACTERIZED BY THE ASSOCIATION OF A MURAMIL-PEPTIDE TO A CYTOQUINE.
AT94910445T ATE226828T1 (en) 1993-03-19 1994-03-21 COMPOSITIONS FOR USE IN HUMAN THERAPY CHARACTERIZED BY THE ASSOCIATION OF A MURAMYL PEPTIDE WITH A CYTOKINE
DK94910445T DK0689449T3 (en) 1993-03-19 1994-03-21 Preparations for use in human therapy, characterized by combining a muramyl peptide with a cytokine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9303787A FR2703251B3 (en) 1993-03-31 1993-03-31 Compositions for application in human therapy, characterized by the association of a muramyl-peptide with a cytokine.

Publications (2)

Publication Number Publication Date
FR2703251A1 FR2703251A1 (en) 1994-10-07
FR2703251B3 true FR2703251B3 (en) 1995-08-04

Family

ID=9445593

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9303787A Expired - Lifetime FR2703251B3 (en) 1993-03-19 1993-03-31 Compositions for application in human therapy, characterized by the association of a muramyl-peptide with a cytokine.

Country Status (1)

Country Link
FR (1) FR2703251B3 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180036974A (en) 2015-07-16 2018-04-10 바이오엑셀 테라퓨틱스 인코포레이티드 A novel approach to the treatment of cancer using immunomodulation

Also Published As

Publication number Publication date
FR2703251A1 (en) 1994-10-07

Similar Documents

Publication Publication Date Title
FR2705842B3 (en) Training set for electromobile.
NO20053106D0 (en) Oral, extended-release analgesic dosage form.
FR2705566B1 (en) New pharmaceutical compositions.
FR2676256B1 (en) DRIVE UNIT FOR DUAL FAN.
EP0847757A4 (en) Medicine comprising hgf gene
FR2712666B1 (en) Luminaire for medical application.
IT1212778B (en) PHARMACEUTICAL COMPOSITIONS ANTI-INFLAMMATORY AND / OR ANALGESIC ADAPTERITY, NON ULCEROGENE.
FR2673276B1 (en) ARC HANDLE.
CA2192480A1 (en) Benzopyrans and their use as therapeutic agents
DE58902899D1 (en) 2 ', 3'-DIDEOXYPURINNUCLEOSIDE / PURINNUCLEOSIDE-PHOSPHORYLASE INHIBITOR COMBINATION THERAPY AND COMPOSITIONS THEREFOR.
ITTO930866A0 (en) PROCEDURE AND MACHINE FOR THE MANUFACTURE OF COVERS FOR BOOKS AND THE SIMILAR, AND COVERS SO MADE.
FR2703251B3 (en) Compositions for application in human therapy, characterized by the association of a muramyl-peptide with a cytokine.
FR2695297B1 (en) Disinfectant agent composition.
FR2702659B1 (en) Compositions for application in human therapy, characterized by the association of a muramyl-peptide with a cytokine.
FR2686251B1 (en) COMPOSITION FOR THE HEALING OF A WOUND.
DE69201478D1 (en) Wear-resistant eutectic aluminum-silicon alloy.
ITRM920535A1 (en) PHARMACEUTICAL COMPOSITION FOR ADMINISTRATION THROUGH THE MUCOSES.
ITTO920793A1 (en) CURING MATURATOR FOR PROVOLONE AND SIMILAR.
FR2697436B1 (en) Adjustable ring softener for gymnastics.
ITRM930338A0 (en) BINDER FOR INSTRUCTIONS FOR THE USE OF ORGANIZATION MEANS.
IT8819447A0 (en) COMPOSITION OF COMPOUNDS THAT IMPROVE THE ANALGESIC, ANTIPYRETIC AND ANTI-INFLAMMATORY ACTIVITY.
ATE82855T1 (en) 2',3'-DIDEOXYPURINUCLEOSIDE/PURINUCLEOSIDPHOSPHORYLASE COMBINATION THERAPY INHIBITOR AND COMPOSITIONS THEREOF.
FR2685204B1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TRANSCUTANEOUS ADMINISTRATION OF FENFLURAMINE.
ITRM920498A0 (en) COMPOSITION FOR THE FIREPROOFING OF POLYMER MATERIALS.
ITRM930635A0 (en) COMPOSITION FOR BISCUITS WITH ANTI-ACID PROPERTIES.